(0.11%) 5 523.25 points
(0.14%) 39 898 points
(0.25%) 19 800 points
(-0.01%) $81.62
(0.46%) $2.82
(-0.29%) $2 337.50
(0.12%) $29.56
(0.32%) $1 005.00
(-0.01%) $0.931
(-0.03%) $10.53
(-0.02%) $0.788
(-0.85%) $87.25
2.17% $ 2.35
Live Chart Being Loaded With Signals
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 31 317 |
Średni wolumen | 0 |
Kapitalizacja rynkowa | 7.08M |
EPS | $-0.430 ( Q2 | 2022-08-12 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.60 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.366 (15.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-17 | Hardy Reginald L | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Hardy Reginald L | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Samant Vijay B | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Lyons Gary A | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Lyons Gary A | Buy | 65 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 10 056 470 | Sell: 193 721 |
Wolumen Korelacja
Brickell Biotech, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Brickell Biotech, Inc. Korelacja - Waluta/Towar
Brickell Biotech, Inc. Finanse
Annual | 2021 |
Przychody: | $404 000 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-22.05 |
FY | 2021 |
Przychody: | $404 000 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-22.05 |
FY | 2020 |
Przychody: | $1.82M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-38.25 |
FY | 2019 |
Przychody: | $7.92M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-202.50 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Brickell Biotech, Inc.
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej